Multicenter Open-Label Tacrolimus Inhalation Powder Trial Evaluating Safety, Tolerability, Efficacy and Pharmacokinetics (pk) in Lung Transplant (ltx) Recipients with Significant Renal Impairment

被引：0
|
作者：
Snell, G. [1 ]
Levvey, B. [1 ]
Westall, G. [1 ]
Christensen, D. [2 ]
Hudson, C. [2 ]
Mikhak, Z. [2 ]
机构：
[1] Alfred Hosp, Melbourne, Vic, Australia
[2] TFF Pharmaceut, Ft Worth, TX USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
638
引用
收藏
页码：S309 / S309
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF SAFETY AND EFFICACY OF EVEROLIMUS WITH REDUCED TACROLIMUS: DESIGN OF A RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Langer, R. M.
    Pape, L.
    Toenshoff, B.
    Dello Strologo, L.
    Ettenger, R.
    Niaudet, P.
    Martzloff, D.
    Vergara, M.
    Balfour, A.
    Cornu-Artis, C.
    PEDIATRIC TRANSPLANTATION, 2013, 17 : 80 - 80
  • [2] Open-label, multicenter study on the safety, tolerability, and efficacy of simulect in pediatric renal transplant recipients receiving triple therapy with cyclosporin, mycophenolate, and corticosteroids
    Turconi, A
    Rilo, LR
    Goldberg, J
    de Boccardo, G
    Garsd, A
    Otero, A
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 672 - 674
  • [3] A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients
    Offner, G
    Broyer, M
    Niaudet, P
    Loirat, C
    Mentser, M
    Lemire, J
    Crocker, JFS
    Cochat, P
    Clark, G
    Chodoff, L
    Korn, A
    Hall, M
    TRANSPLANTATION, 2002, 74 (07) : 961 - 966
  • [4] A 6-Month, Open-Label, Multicenter Clinical Study in Korean De Novo Renal Transplant Patients Evaluating the Efficacy, Safety, and Tolerance of Myfortic Concomitantly Used with Tacrolimus
    Ju, M. K.
    Park, S. H.
    Kim, S. J.
    Moon, I. S.
    Kim, Y. S.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (01) : 144 - 146
  • [5] Renal function, efficacy and safety postconversion from twice- to once-daily tacrolimus in stable liver recipients: an open-label multicenter study
    Sanko-Resmer, Joanna
    Boillot, Olivier
    Wolf, Philippe
    Thorburn, Douglas
    TRANSPLANT INTERNATIONAL, 2012, 25 (03) : 283 - 293
  • [6] Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial
    Abdellatif, Abdul
    Zhao, Lin
    Chamberlain, Jason
    Cherny, Katya
    Xin, Yan
    Marder, Brad A.
    Scandling, John D.
    Saag, Kenneth
    CLINICAL TRANSPLANTATION, 2023, 37 (09)
  • [7] Pegloticase for Uncontrolled Gout in Kidney Transplant Recipients: Provisional Data Report of a Multicenter, Open-Label, Efficacy and Safety Study
    Abdellatif, AbdulA.
    Zhao, Lin
    Peloso, Paul M.
    Cherny, Katya
    Marder, Brad
    Scandling, John D.
    Saag, Kenneth G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 647 - 648
  • [8] Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open-label, phase 2 trial
    Ulys, Albertas
    Jankevicus, Feliksas
    Jievaltas, Mindaugas
    Venckus, Raimundas
    Auskalnis, Stasys
    Kardelis, Zygimantas
    Barisiene, Marija
    Maclean, Carol M.
    van Os, Steve
    Larsen, Finn
    PROSTATE, 2024, 84 (06): : 584 - 598
  • [9] A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
    Bola Tayo
    Lesley Taylor
    Farhad Sahebkar
    Gilmour Morrison
    Clinical Pharmacokinetics, 2020, 59 : 747 - 755
  • [10] A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
    Tayo, Bola
    Taylor, Lesley
    Sahebkar, Farhad
    Morrison, Gilmour
    CLINICAL PHARMACOKINETICS, 2020, 59 (06) : 747 - 755
12345